Global Peripheral IV Catheters Market Professional Survey Report 2019

2 Global Peripheral IV Catheters Quarterly Market Size Analysis

• 2.1 Peripheral IV Catheters Business Impact Assessment - COVID-19
  • 2.1.1 Global Peripheral IV Catheters Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Peripheral IV Catheters Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Peripheral IV Catheters Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Peripheral IV Catheters Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Peripheral IV Catheters Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Peripheral IV Catheters Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Peripheral IV Catheters Market
• 3.5 Key Manufacturers Peripheral IV Catheters Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Peripheral IV Catheters Segments, By Type

• 4.1 Introduction
  • 1.4.1 Safety
  • 1.4.2 Conventional
• 4.2 By Type, Global Peripheral IV Catheters Market Size, 2019-2021
  • 4.2.1 By Type, Global Peripheral IV Catheters Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Peripheral IV Catheters Price, 2020-2021

5 Impact of Covid-19 on Peripheral IV Catheters Segments, By Application

• 5.1 Overview
  • 5.5.1 Hospitals
  • 5.5.2 ASC
  • 5.5.3 Clinics
  • 5.5.4 Home Healthcare
  • 5.5.5 Other End Users
• 5.2 By Application, Global Peripheral IV Catheters Market Size, 2019-2021
  • 5.2.1 By Application, Global Peripheral IV Catheters Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Peripheral IV Catheters Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Tangent Medical Technologies
  • 7.1.1 Tangent Medical Technologies Business Overview
  • 7.1.2 Tangent Medical Technologies Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.1.3 Tangent Medical Technologies Peripheral IV Catheters Product Introduction
  • 7.1.4 Tangent Medical Technologies Response to COVID-19 and Related Developments
• 7.2 Smith Medical
  • 7.2.1 Smith Medical Business Overview
  • 7.2.2 Smith Medical Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.2.3 Smith Medical Peripheral IV Catheters Product Introduction
  • 7.2.4 Smith Medical Response to COVID-19 and Related Developments
• 7.3 B. Braun Melsungen
  • 7.3.1 B. Braun Melsungen Business Overview
  • 7.3.2 B. Braun Melsungen Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.3.3 B. Braun Melsungen Peripheral IV Catheters Product Introduction
  • 7.3.4 B. Braun Melsungen Response to COVID-19 and Related Developments
• 7.4 C. R. Bard
  • 7.4.1 C. R. Bard Business Overview
  • 7.4.2 C. R. Bard Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.4.3 C. R. Bard Peripheral IV Catheters Product Introduction
  • 7.4.4 C. R. Bard Response to COVID-19 and Related Developments
• 7.5 Becton
  • 7.5.1 Becton Business Overview
  • 7.5.2 Becton Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.5.3 Becton Peripheral IV Catheters Product Introduction
  • 7.5.4 Becton Response to COVID-19 and Related Developments
• 7.6 Dickinson and Company
  • 7.6.1 Dickinson and Company Business Overview
  • 7.6.2 Dickinson and Company Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.6.3 Dickinson and Company Peripheral IV Catheters Product Introduction
  • 7.6.4 Dickinson and Company Response to COVID-19 and Related Developments
• 7.7 Argon Medical Devices
  • 7.7.1 Argon Medical Devices Business Overview
  • 7.7.2 Argon Medical Devices Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.7.3 Argon Medical Devices Peripheral IV Catheters Product Introduction
  • 7.7.4 Argon Medical Devices Response to COVID-19 and Related Developments
• 7.8 Terumo Corporation
  • 7.8.1 Terumo Corporation Business Overview
  • 7.8.2 Terumo Corporation Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.8.3 Terumo Corporation Peripheral IV Catheters Product Introduction
  • 7.8.4 Terumo Corporation Response to COVID-19 and Related Developments
• 7.9 Vygon SA
  • 7.9.1 Vygon SA Business Overview
  • 7.9.2 Vygon SA Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.9.3 Vygon SA Peripheral IV Catheters Product Introduction
  • 7.9.4 Vygon SA Response to COVID-19 and Related Developments
• 7.10 Teleflex
  • 7.10.1 Teleflex Business Overview
  • 7.10.2 Teleflex Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.10.3 Teleflex Peripheral IV Catheters Product Introduction
  • 7.10.4 Teleflex Response to COVID-19 and Related Developments
• 7.11 Vigmed AB
  • 7.11.1 Vigmed AB Business Overview
  • 7.11.2 Vigmed AB Peripheral IV Catheters Quarterly Production and Revenue, 2020
  • 7.11.3 Vigmed AB Peripheral IV Catheters Product Introduction
  • 7.11.4 Vigmed AB Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Peripheral IV Catheters Supply Chain Analysis
  • 8.1.1 Peripheral IV Catheters Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Peripheral IV Catheters Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Peripheral IV Catheters Distribution Channels
  • 8.2.2 Covid-19 Impact on Peripheral IV Catheters Distribution Channels
  • 8.2.3 Peripheral IV Catheters Distributors
• 8.3 Peripheral IV Catheters Customers

9 Key Findings

10 Appendix

• 10.1 About Us